Correspondence george.kassiotis@crick.ac.uk In Brief ' 'Helper'' CD4 T cells can also exhibit granzyme-mediated cytotoxicity. Donnarumma et al. investigate the conditions that induce CD4 CTLs and describe the dominant effect of the class of infecting virus. They uncover a unique transcriptional signature of CD4 CTLs and its multi-layered control.
SUMMARY

CD4
+ T cells develop distinct and often contrasting helper, regulatory, or cytotoxic activities. Typically a property of CD8 + T cells, granzyme-mediated cytotoxic T cell (CTL) potential is also exerted by CD4 + T cells. However, the conditions that induce CD4 + CTLs are not entirely understood. Using single-cell transcriptional profiling, we uncover a unique signature of Granzyme B (GzmB) + CD4 + CTLs, which distinguishes them from other CD4 + T helper (Th) cells, including Th1 cells, and strongly contrasts with the follicular helper T (Tfh) cell signature. The balance between CD4 + CTL and Tfh differentiation heavily depends on the class of infecting virus and is jointly regulated by the Tfh-related transcription factors Bcl6 and Tcf7 (encoding TCF-1) and by the expression of the inhibitory receptors PD-1 and LAG3. This unique profile of CD4 + CTLs offers targets for their study, and its antagonism by the Tfh program separates CD4 + T cells with either helper or killer functions.
INTRODUCTION
CD4
+ TCRab T cells centrally orchestrate multiple arms of innate and adaptive immunity using distinct and, often, opposing effector and regulatory functions through the differentiation of distinguishable functional CD4 + T cell subsets (O'Shea and Paul, 2010; Swain et al., 2012; Zhu et al., 2010) . Several such functional subsets are now recognized, including the prototypic Th1 and Th2 subsets but also the Th17, follicular helper (Tfh), and regulatory T (Treg) subsets, each characterized by a well-defined transcriptional program (Crotty, 2014 ; O'Shea and Paul, 2010; Swain et al., 2012; Vinuesa et al., 2016; Zhu et al., 2010) . Based on the increasingly appreciated diversity of CD4 + T cell activities, additional functional subsets have been proposed. These include CD4 + with cytotoxic T cell (CTL) potential, able to kill target cells through the release of granzyme-containing granules (Brown et al., 2016; Cheroutre and Husain, 2013; Swain et al., 2012) .
Cytotoxicity is typically associated with CD8 + T cells and natural killer (NK) cells and has not been conventionally considered a CD4 + T cell function (Cullen et al., 2010) . Indeed, ''helper'' and ''cytotoxic'' terms are often used to describe the major histocompatibility complex (MHC) class-II-restricted CD4 + and MHC class-I-restricted CD8 + TCRab T cell lineages, respectively. Commitment of developing thymocytes to the CD4 + or CD8 + lineage and acquisition of either helper or cytotoxic activity is controlled by the antagonistic transcription factors ThPOK and Runx3. ThPOK suppresses the cytotoxic program in CD4 + thymocytes and mature T cells, whereas Runx3 promotes this program in CD8 + T cells (Cheroutre and Husain, 2013) .
Despite transcriptional repression of the cytotoxic program during CD4 + T cell development, MHC class-II-restricted, cellcontact-dependent cytotoxicity has long been observed in a variety of conditions, both in humans and experimental animals (Brown, 2010; Brown et al., 2016; Cheroutre and Husain, 2013; Soghoian and Streeck, 2010; Swain et al., 2012; van de Berg et al., 2008) . Although CD4 + T cells can kill target cells also through surface expression of tumor necrosis factor (TNF) family members, including FasL and TRAIL, accumulated evidence has established their ability to develop and use granzyme-mediated cytotoxic activity (Brown et al., 2016; Cheroutre and Husain, 2013) . Pivotal recent studies with a ThPOK-reporter mouse strain uncovered considerable plasticity of the ''helper'' program in CD4 + T cells, with loss of ThPOK expression and transcriptional switch to the ''cytotoxic'' program. (the gene encoding ThPOK) and acquire the expression of Runx3 Reis et al., 2013) . This transcriptional reprogramming is accompanied by the expression of genes more characteristic of the CD8 + lineage, such as Cd8a, Crtam, and Eomes, and, importantly, also by the development of GzmB-mediated cytotoxic potential Reis et al., 2013) .
These studies emphasize the similarities between CD8 + T cells and reprogrammed CD4 + CTLs and suggest that the latter subset should be viewed as distinct from other CD4 + Th cell subsets (Cheroutre and Husain, 2013) . Despite these significant advances, the factors that dictate CD4 + CTL differentiation are still incompletely understood. Also unclear are the precise place of CD4 + CTLs in the transcriptional spectrum of all Th cell subsets and whether the CD4 + CTL program is compatible with other Th cell differentiation pathways.
Here, we investigated the priming requirements for CD4 + CTLs and the signals that either promote or inhibit CD4 + CTL differentiation. To overcome the lack of a reliable marker for the unambiguous identification of CD4 + CTLs, we applied global transcriptional analysis of single CD4 + T cells. We report that CD4 + CTL differentiation strictly depends on the infecting or immunizing virus, with retroviral infection and adenovirus-based vaccination at the low and high ends of the spectrum, respectively. Moreover, our results uncovered regulation of the CD4 + CTL program by expression of inhibitory receptors and direct antagonism by the Tfh program.
RESULTS
CD4 + CTL Development Depends on Infecting Virus
We have previously described an adoptive transfer system that allows the study of the CD4 + T cell response to the dominant H2-A b -restricted env 122-141 epitope within the Friend murine leukemia virus (F-MLV) gp70 glycoprotein (Merkenschlager et al., 2016; . Small numbers of allotypically marked EF4.1 TCRb-transgenic CD4 + T cells were transferred into wild-type (WT) C57BL/6 (B6) recipients and primed either by infection with Friend virus (FV) or by immunization with a human Adenovirus 5 (Ad5)-based vector expressing F-MLV gp70 (Ad5.pIX-gp70) (Bayer et al., 2010) . FV is a retroviral complex of F-MLV and spleen focus-forming virus (SFFV) that causes chronic infection in B6 mice (Hasenkrug and Chesebro, 1997; Tsuji-Kawahara et al., 2013) , whereas the Ad5.pIX-gp70 vaccine vector is replication defective (Bayer et al., 2010) . Microarraybased comparison of EF4.1 env-reactive CD4 + T cells primed by Ad5.pIX-gp70 indicated elevated transcription of CTL-related genes, in comparison with T cells primed by FV . Indeed, on day 7 of the response, env-reactive effector CD4 + T cells expressed significantly higher amounts of Gzmb mRNA when primed by Ad5.pIX-gp70 than when primed by FV ( Figure 1A) . Moreover, the hosts exhibited significantly higher levels of MHC class-II-restricted in vivo cytotoxicity against env 122-141 -pulsed B cell targets when primed by Ad5.pIX-gp70 than when primed by FV ( Figure 1B ). More efficient in vivo killing also correlated with enhanced GzmB-mediated in vitro killing, by purified env-reactive CD4 + T cells, of B cells loaded with a fluorogenic GzmB substrate ( Figure 1C ).
Consistent with higher Gzmb expression and GzmB-mediated killing at the population level, env-reactive effector CD4 + T cells contained a significantly higher proportion of GzmB + cells if primed by Ad5.pIX-gp70 than if primed by FV ( Figure 1D ). Notably, GzmB protein expression was detected in env-reactive effector CD4 + T cells even without in vitro restimulation (Figure S1A) , suggesting that it reflected in-vivo-induced production. Moreover, EF4.1 env-reactive CD4 + T cells, additionally carrying an allele encoding a fusion of GzmB and tdTomato fluorescent protein (Mouchacca et al., 2013) , contained a significantly higher frequency of GzmB-tdTomato + cells when primed by Ad5.pIXgp70 than when primed by FV ( Figure S1B ). Together, these data support the idea that GzmB production was induced in vivo in splenic CD4 + T cells during Ad5.pIX-gp70 immunization. Furthermore, Ad5.pIX-gp70 vaccination induced a significantly higher frequency of GzmB + cells in splenic host effector
arguing that the difference between the two immunogens was not restricted to CD4 + T cells or to TCR (T cell-receptor)-transgenic T cells. One notable difference between FV infection and Ad5.pIXgp70 immunization is their ability to prime different TCR clonotypes Figure S3C ). These results indicated a small effect of TCR usage on CD4 + CTL differentiation, which was, however, overshadowed by other properties of the two viruses. Lastly, different immunization regimens elicited distinct frequencies of GzmB + cells within env-reactive effector CD4 + T cells ( Figure 1E ). These included non-persisting infection with attenuated N-tropic F-MLV (F-MLV-N) (Dittmer et al., 1998) or transient env [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] peptide immunization, which failed to induce GzmB + cells, and transplantation of the FV-induced FBL-3 tumor cell line (Klarnet et al., 1989) , which induced moderate levels of GzmB + cells ( Figure 1E ). They also included infection with a replication-competent and persisting mouse-cytomegalovirus (mCMV)-based vector encoding F-MLV env, which also induced readily detectable GzmB + cells ( Figure 1E ). Thus, properties of the infecting or immunizing virus, independently of its ability to persist in the host, largely determine the efficiency of antigenspecific CD4 + T cell differentiation into CTLs, with Ad5.pIXgp70 outperforming FV.
Antagonistic CD4 + CTL and Tfh Development Both TCR usage and the nature of infecting virus can heavily influence Th subset differentiation, which is reflected in the corresponding transcriptional profiles. The necessary cell processing for intracellular GzmB staining precluded further transcriptional analysis between GzmB + and GzmB À CD4 + T cells. To overcome this limitation, we performed single-cell RNA sequencing of env-specific CD4 + T cells primed either by FV or Ad5.pIXgp70. Consistent with flow-cytometric detection of GzmB production, FV induced Gzmb expression in 3/57 and 1/65 cells (an average of 3.2%), whereas Ad5.pIX-gp70 induced Gzmb expression in 6/42 and 4/45 cells (an average of 11.5%) analyzed in two independent runs (p = 0.022, Fisher's exact test) (Figure 2A) . In contrast, expression of other cytotoxic mediators, such as Tnfa, Fasl, and Tnfsf10, was comparable between FV and Ad5.pIX-gp70 priming ( Figure S4 ). It should be noted that gene expression assessment by single-cell RNA sequencing represents the lower limit, as it captures only a fraction of the genes expressed in a given cell. This is evident in the transcription of the Cd4 gene, which is not detected in all of the CD4 + T cells analyzed (Figure 2A ).
Single-cell transcriptional analysis revealed another notable difference between FV-primed and Ad5.pIX-gp70-primed CD4 + T cells: a significantly higher proportion of the former transcribed Bcl6 (p = 0.025, Fisher's exact test) ( Figure 2B ), which is essential for Tfh development (Crotty, 2014; Vinuesa et al., 2016) . In contrast, the two types of CD4 + T cells displayed comparable transcription of Tcf7 ( Figure 2B ), encoding the transcription factor TCF-1, which has been recently found to promote Tfh development at multiple levels, including through induction of Bcl6 transcription (Choi et al., 2015; Wu et al., 2015; Xu et al., 2015) .
Independently assessed in CD4 + T cell populations, levels of Tcf7 were not significantly lower in Ad5.pIX-gp70-primed than in FV-primed CD4 + T cells, whereas levels of Bcl6 were (Figure 2C) . Together, these results suggested that the degree of CTL and Tfh differentiation in env-specific CD4 + T cells are inversely correlated and dictated by the priming virus.
To examine whether CTL differentiation was inhibited by competing Th programs, we compared the gene transcripts that distinguished Gzmb + cells (Table S1 ). Interestingly, Gzmb + cells primed by either virus were characterized by specific loss of Tcf7 expression, among a selected set of genes ( Figure 2D ). Conversely, Gzmb + cells were characterized by elevated expression of several other genes, including Cxcr6, Entpd1 (encoding CD39), Slamf1 (encoding CD150), and Cd226 ( Figure 2D ), which were further validated by flow cytometry ( Figure 2E ). These transcriptional differences were also significant when Gzmb À and Gzmb + cells primed by Ad5.pIX-gp70 only were analyzed (Figure S5) . Accordingly, none of the Ad5.pIX-gp70-primed Gzmb + cells expressed Bcl6, and half of them expressed the antagonistic transcription factor Blimp-1, encoded by Prdm1, in sharp contrast to Gzmb À cells ( Figure 2F ). Also in contrast to Gzmb À cells, which were nearly all Tcf7 + and most also expressed Lef1, encoding the TCF-1 homolog LEF-1, Gzmb + cells only sporadically expressed Tcf7 and Lef1 ( Figure 2F ; Figure S6A ). The balance of Zbtb7b (encoding ThPOK) and Runx3 transcription, associated with the CD4 + and CD8 + lineages, respectively (Cheroutre and Husain, 2013) , was also altered in Ad5.pIXgp70-primed Gzmb + T cells ( Figure 2F ; Figure S6A ). This observation is consistent with previous reports on intestinal CD4 + CTLs, in which Runx3 expression is associated with CD8a expression Reis et al., 2013) . In contrast to intestinal CD4 + CTLs, however, the altered balance of Zbtb7b and Runx3 transcription in splenic Gzmb + CD4 + T cells induced by Ad5.pIX-gp70 did not lead to transcription of either the Cd8a or Cd8b1 genes or the acquisition of Crtam or Eomes expression ( Figure S6B ). Lastly, transcription of Cd5 and Nr4a1 (encoding Nur77), which could be indicative of the strength of TCR signaling experienced by env-specific CD4 + T cells, did not significantly differ between Gzmb À and Gzmb + cells ( Figure S6C ), suggesting that TCR signal strength is not the primary determinant of CD4 + CTL differentiation. Collectively, these findings point to a CD4 + CTL-specific transcriptional signature, characterized by acquisition of Runx3 transcription and, importantly, downregulation of Tfh-related transcription, particularly of Tcf7.
Bcl6 Suppresses CD4 + CTL Development
Loss of Tfh-specific transcription in Gzmb + CD4 + T cells suggested that the TCF-1-Bcl6 nexus was incompatible with, or actively inhibiting, CD4 + CTL differentiation. To test this possibility, we used conditional ablation of Bcl6 in env-specific effector CD4 + T cells, which were transferred into WT hosts ( Figure S7 ). This was achieved by expression of Cre in donor CD4 + T cells under the control of the Tnfrsf4 promoter (Tnfrsf4 Cre ) (Klinger et al., 2009) . This promoter activates in the majority of CD4 + T cells, only following antigen recognition, thus avoiding any effects of gene deletion during T cell development and prior to activation . Effector CD4 + T cells that activated the Tnfrsf4 promoter were identified using a Cre-conditional yellow fluorescent protein (YFP) reporter (Gt(ROSA)26Sor YFP ) allele.
A Cre-conditional Bcl6 (Bcl6 fl ) allele (Kaji et al., 2012) was also introduced in separate donor EF4.1 mice. These combinations created four separate populations of env-specific donor CD4 + T cells ( Figure 3A ; Figure S7 (Merkenschlager et al., 2016) . Transcriptional analysis of env-specific donor CD4 + T cell populations primed by either virus confirmed significantly higher Bcl6 expression in FV-primed than in Ad5.pIX-gp70-primed T cells, regardless of Tnfrsf4 promoter activity ( Figure 3B ). Moreover, Bcl6 expression was lost in the YFP + , but not the YFP À , fraction of Bcl6 fl T cells ( Figure 3B ), validating the approach.
Loss of Bcl6 expression in the YFP + fraction was accompanied by significant gain in expression of Prdm1, as well as of Gata3, Tbx21, and Ifng ( Figure 3B ), but not of Foxp3 or Rorc ( Figure S8 ), suggesting that Bcl6 was suppressing the Th1 and Th2 programs. This effect of Bcl6 deletion on CD4 + T cell differentiation was further confirmed by intracellular staining for T-bet (encoded by Tbx21) and interferon (IFN)-g ( Figure S9 ). Higher levels of T-bet and IFN-g were induced by FV infection than Ad5.pIXgp70 immunization in Bcl6 wt CD4 + T cells, and these were not further elevated in Bcl6 fl CD4 + T cells ( Figure S9 ). In contrast, the low levels of T-bet and IFN-g induced by Ad5.pIX-gp70 immunization in Bcl6 wt CD4 + T cells were significantly elevated in Figure S9 ).
In addition to enhancing differentiation of other Th cell subsets, loss of Bcl6 expression led to a striking upregulation of Gzmb transcription, specifically in Ad5.pIX-gp70-primed CD4 + T cells ( Figure 3B ). Importantly, the gain in Gzmb expression in the latter population (>13-fold) was considerably more pronounced than the gain in the transcription of the other genes examined (2.2-to 3.8-fold) ( Figure 3B ). The significantly heightened transcription of Gzmb, specifically in Ad5.pIX-gp70 immunization, was additionally confirmed by intracellular staining for GzmB in the total env-specific Bcl6 fl CD4 + T cell population, containing both Bcl6-deleted and non-deleted cells ( Figure 4A ). To gain better insight into the transcriptional profile of only the Bcl6-deleted env-specific CD4 + T cells, without the need for in vitro restimulation, we next subjected the purified YFP + fraction of Bcl6 fl CD4 + T cells to single-cell RNA sequencing. This analysis demonstrated a significant increase in the frequency of Gzmb + cells in Bcl6-deleted env-specific CD4 + T cells following priming by Ad5.pIX-gp70 ( Figure 4B ). Indeed, nearly 40% of these cells were positive for Gzmb transcripts ( Figure 4B ). In contrast, the frequency of Gzmb + cells in Bcl6-deleted envspecific CD4 + T cells primed by FV did not change significantly (Figures 2A and 4B ). These data with Bcl6-deleted populations and purified single cells suggested that Bcl6 was restraining the CTL program in env-specific CD4 + T cells, at least during Ad5.pIX-gp70 priming.
To relate the effect of Bcl6 deletion on Gzmb expression, we examined the transcription of additional effector molecules in single WT or Bcl6-deleted env-specific CD4 + T cells. A high proportion (68%) of WT CD4 + T cells primed by FV expressed Il21
(which, in these settings, was characteristic of the Tfh response), and a smaller proportion (14%) expressed Il10, with only partial overlap with Ifng expression ( Figure 4C ). Although loss of Bcl6 during FV infection did not markedly reduce Il21 expression, it did significantly enhance expression of both Ifng (2.3-fold) and Il10 (4.7-fold), which were now co-expressed in the majority of Bcl6-deleted CD4 + T cells ( Figure 4C ). In stark contrast to FV infection, Ad5.pIX-gp70 immunization induced very little Il21 or Il10 expression in either WT or Bcl6-deleted env-specific CD4 + T cells ( Figure 4C ). Moreover, Bcl6 deletion induced a more modest gain in Ifng-expressing cells (1.5-fold) after Ad5.pIXgp70 priming than after FV priming ( Figure 4C ). Collectively, these data argued that Bcl6 suppressed specifically CTL differentiation of env-specific CD4 + T cells during Ad5.pIX-gp70 priming.
CD4 + CTL and Th1 Cells Are Transcriptionally Distinct
GzmB expression is often considered a part of the Th1 program of CD4 + T cell differentiation. Indeed, some of the genes, such as Slamf1 (encoding CD150), whose expression characterized Gzmb + cells (Figures 2D and 2E) , are also used to distinguish
Th1 from Tfh cells (Crotty, 2014; Vinuesa et al., 2016) . Singlecell transcriptional analysis revealed that, independently of priming virus or Bcl6 sufficiency, over half (57%) of Gzmb + cells co-expressed Ifng ( Figure 5A ). Similar results were obtained at the protein level ( Figure 5B ), indicating a close relationship between GzmB and IFN-g production. However, the strong Ifng expression in FV infection without concomitant Gzmb expression, and the inverse during Ad5. ) revealed significantly higher CD150 expression in the former ( Figure 5C ).
To comprehensively explore potential transcriptional differences between Th1 and CTL CD4 + T cells, we compared the transcriptional profiles of env-specific CD4 + T cells expressing priming was analyzed separately, whereas it narrowly lost significance when FV priming was analyzed in isolation due to the low Figure 5E ), suggesting that the combination of these two markers was sufficient to distinguish between the Th1 and CD4 + CTLs.
To confirm the distinguishing pattern of Prdm1 and Tcf7 expression of Gzmb + CD4 + T cells, we used EF4.1 TCRb-transgenic CD4 + T cells additionally carrying a GFP reporter into the Prdm1 locus (Kallies et al., 2009) . As GFP insertion disrupts the Prdm1 gene in these mice (Kallies et al., 2009) , we used donors heterozygous for the Prdm1 Gfp allele to prevent loss of function of the encoded Blimp1 in the adoptively transferred CD4 + T cells. Following Ad5.pIX-gp70 immunization, a small proportion ($8%) of donor env-specific effector CD4 + T cells displayed Blimp1-GFP expression ( Figure 5F ) and contained Prdm1 transcripts ( Figure 5G ). Notably, this fraction was also characterized by paucity of Tcf7 and overabundance of Gzmb transcripts, relative to the Blimp1-GFP À fraction ( Figure 5G ). Thus, loss of Tcf7 expression and induction of Prdm1 expression could differen- Figure 6A ). By comparison, following Ad5.pIX-gp70 immunization, Ctla4 expression was comparable in Gzmb À cells, but expression of Pcdc1 was reduced to 36%, and expression of Lag3 was now largely absent (8%) ( Figure 6A) . Notably, the difference in expression of inhibitory receptors between the two viruses was more pronounced in Gzmb + cells, which, in the case of FV priming, co-expressed all four inhibitory receptors ( Figure 6A ). In contrast, Gzmb + cells primed by Ad5.pIX-gp70 lacked expression of Pcdc1 and Lag3 ( Figure 6A ). This difference between the two viruses in the induction of Pcdc1 and Lag3 expression was also confirmed at the PD-1 and LAG3 protein level. Consistent with the RNA expression data, PD-1 was expressed by nearly all env-specific CD4 + T cells, but at significantly higher levels in FV infection than in Ad5.pIX-gp70 immunization ( Figures 6B and 6C) . Similarly, a much larger fraction of env-specific CD4 + T cells exhibited LAG3 surface expression when primed by FV than by Ad5.pIXgp70 ( Figure 6B ), a difference that was also reflected in the intensity of LAG3 staining of the entire population ( Figure 6C ). Thus, Figure 5C ). In contrast, significant expression of both Pcdc1 and Lag3 was induced in Gzmb + env-specific CD4 + T cells uniquely by FV infection but not Ad5.pIX-gp70 immunization. The pattern of inhibitory receptors expressed by FV-primed env-specific CD4 + T cells was suggestive of an exhausted phenotype (Crawford et al., 2014) , which was investigated further. PD-1 expression was more consistent with antigeninduced activation of effector CD4 + T cells than with cellular exhaustion, as it was also induced by Ad5.pIX-gp70, albeit to a lower intensity per cell ( Figure 6C ), and was also substantially reduced quickly after the peak of the effector response to FV infection ( Figure S12 ). Moreover, effector CD4 + T cells isolated from acute FV infection were transcriptionally distinct from typical exhausted CD4 + T cells isolated from chronic lymphocytic choriomeningitis virus (LCMV) infection (Crawford et al., 2014 ; Figure S13A ), suggesting that expression of inhibitory receptors by FV-primed effector CD4 + T cells was part of acute effector differentiation rather than of the exhaustion that characterizes chronic viral infections. Nevertheless, expression of inhibitory receptors, particularly of PD-1 and LAG3, by env-specific CD4 + T cells during acute FV infection could still influence cellular activation or CTL differentiation. To this end, we treated WT recipients of env-specific CD4 + T cells with PD-1-and LAG3-blocking antibodies during the course of FV infection. Although blockade of either PD-1 or LAG3 separately had only a modest effect, the combined PD-1 and LAG3 blockade significantly increased in the frequency of Gzmb + cells in donor CD4 + T cells ( Figure 6D ; Figure S14 ), supporting their role in restraining CD4 + CTL differentiation. In contrast, the PD-1 and LAG3 blockade did not appreciably alter clonal expansion of donor CD4 + T cells or their production of IFN-g and TNF-a ( Figure S15 ). The high levels of PD-1 expression in env-specific CD4 + T cells responding to FV infection were previously shown to require cognate interaction between T cells and B cells (Ploquin et al., 2011) . Therefore, we used B cell deficiency as an alternative to PD-1 blockade. Indeed, a significantly higher proportion of env-specific CD4 + T cells expressed intracellular GzmB when transferred into B cell-deficient Ighm À/À hosts than into WT hosts ( Figure 6D ). These findings supported the premise that PD-1 and LAG3 posed a further block in CD4 + CTL differentiation, in addition to Bcl6 expression. To test this premise directly, we combined Bcl6 deficiency in env-specific CD4 + T cells with PD-1 and LAG3 blockade. As before ( Figure 4A ), Bcl6 deficiency alone did not significantly enhance CD4 + CTL differentiation during FV infection ( Figure 6D ). In contrast, the combination of Bcl6 deficiency and PD-1 and LAG3 blockade markedly increased the proportion of Gzmb + cells ($3-fold) ( Figure 6D ) to levels comparable with those induced by Bcl6 deficiency in Ad5.pIX-gp70 immunization ( Figure 4B ). Thus, PD-1 and LAG3 were preventing Bcl6-deficient env-specific CD4 + T cells from acquiring GzmB expression during FV infection, representing an additional level of CD4 + CTL differentiation control. Figures S12, S13 , S14, and S15.
DISCUSSION
Since the earliest descriptions of MHC class-II-restricted cytotoxic activity in CD4 + T cells nearly 4 decades ago, a number of studies have implicated CD4 + CTLs in antiviral and antitumor immunity, as well as in autoimmune and inflammatory conditions (Brown, 2010; Brown et al., 2016; Cheroutre and Husain, 2013; Soghoian and Streeck, 2010; van de Berg et al., 2008) . Nevertheless, the priming requirements for CD4 + CTLs or their phenotypic overlap with other CD4 + Th subsets have only recently begun to emerge. Here, we described the transcriptional profile of CD4 + CTLs as the antipode of the Tfh profile. We provided evidence to suggest multilayered control of CD4 + CTL differentiation: first, by the TCF-1-Bcl6 nexus driving Tfh polarization, and second, inhibition by PD-1 and LAG3.
Study of CD4 + CTLs has been hampered by the lack of distinctive markers that are compatible with further characterization of these cells. Although MHC class-II-restricted cytotoxic activity has been amply documented, it has not been consistently attributed to granzyme-mediated killing, as opposed to killing mediated by secreted or membrane-bound cytokines, including IFN-g, expressed by Th1 cells, or members of the TNF family, expressed by multiple CD4 + Th cell subsets (Brown et al., 2016; Cheroutre and Husain, 2013) . Even when production of GzmB was used for the identification of CD4 + CTLs, a certain degree of phenotypic overlap with Th1 cells was noted (Hua et al., 2013) , and indeed, GzmB-producing CD4 + T cells are still regarded in the literature as a variant of the Th1 subset. This view is further supported by a potential developmental connection between CD4 + CTLs and Th1 cells (Cheroutre and Husain, 2013) .
Indeed, GzmB-producing cells often also express typical Th1 products, including IFN-g. CD4 + CTL differentiation, particularly in response to interleukin-2 (IL-2) and IFN-a stimulation, has also been suggested to rely on the Th1-related transcription factor T-bet (encoded by the Tbx21 gene), which can bind directly to the Gzmb promoter (Hua et al., 2013 Reis et al., 2013; Takeuchi et al., 2016 (Choi et al., 2015; Wu et al., 2015; Xu et al., 2015) . Interestingly, Tcf7 and Lef1 gene deletion in CD4 + T cells in two of these studies promoted transcriptional features of Th1 cells, as well as of CD4 + CTLs, including Gzmb expression (Choi et al., 2015; Xu et al., 2015) . The acquisition of CTL-related characteristics by Tcf7-deficient CD4 + T cells in these population studies was interpreted as part of enhanced Th1 responses (Choi et al., 2015; Xu et al., 2015 (Choi et al., 2015; Wu et al., 2015; Xu et al., 2015) . Previous studies demonstrated defective GzmB expression by Blimp1-deficient CD4 + T cells, whereas Blimp1 overexpression enhances CD4 + CTL differentiation (Gong and Malek, 2007; Hua et al., 2013) . These studies suggest that CD4 + CTL differentiation requires Blimp1, which is thought to enhance T-bet binding to the promoters of CTL-related genes, including Gzmb (Gong and Malek, 2007; Hua et al., 2013 Manzke et al., 2013) , suggesting extrinsic regulation. These data imply that both extrinsic regulation, in the form of Treg cells, and intrinsic regulation, in the form of inhibitory receptors in effector T cells, are effectively exploited by retroviruses.
Although incompletely understood, the induction of inhibitory receptors in virus-specific CD4 + T cells during FV infection requires cognate interaction with B cells (Ploquin et al., 2011) . Expression of PD-1 in virus-specific CD4 + T cells, for example, is significantly reduced in the absence of B cell antigen presentation during FV infection (Ploquin et al., 2011) or endogenous antigen expression (Han et al., 2010) . In keeping with these observations, B cell deficiency also enhanced CD4 + CTL differentiation in this study. These findings are entirely consistent with a critical role for B cells in deciding the balance between Tfh and CTL differentiation of interacting CD4 + T cells. B cells play a well-described role in stabilizing the Tfh program (Crotty, 2014; Vinuesa et al., 2016) , and, together with inducing PD-1 expression in CD4 + T cells, they inhibit CD4 + CTL differentiation. Such a role for B cells would ensure efficient antibody production at the expense of CD4 + T cell-mediated immunity. Indeed, B cells inhibit antibody-independent CD4 + T cell-mediated protection against tumors (Qin et al., 1998) or FV-induced erythroblastosis (Pike et al., 2009) . A critical influence of the type of antigen-presenting cell on Tfh and CTL differentiation may also underlie the difference in the efficiency with which distinct viruses or viral vaccines elicit either Tfh or CD4 + CTLs. Elucidation of the role of distinct antigenpresenting cell types in this process may hold the key to both understanding and controlling the balance between Tfh and CD4 + CTLs.
Overall, using single-cell analysis, our study revealed the transcriptional signature of Gzmb-expressing CD4 + T cells. Their unique transcriptional features not only support the notion of a distinguishable CD4 + CTL subset but also provide markers for future identification and further longitudinal study of CD4 /BoyJ) mice, TCRb-transgenic EF4.1 mice , TCRab doubly transgenic EVa2 mice (Merkenschlager et al., 2016) , Rag1-deficient (Rag1 À/À ) mice (Mombaerts et al., 1992) , B cell-receptor-deficient (Ighm À/À ) mice (Kitamura et al., 1991) ) mice (Young et al., 2012) , mice with a targeted insertion of GFP into the Prdm1 locus (Kallies et al., 2009 ) (Blimp1-GPF), and mice with a targeted insertion of tdTomato fluorescent protein into the Gzmb locus (Mouchacca et al., 2013 ) (GzmB-tdTomato) were all on the B6 genetic background and were maintained at the Francis Crick Institute's animal facilities. All animal experiments were approved by the ethical committee of the Francis Crick Institute and were conducted according to local guidelines and UK Home Office regulations under the Animals (Scientific Procedures Act) 1986 (ASPA).
Retroviral Infection and Immunization
Details of infections, immunizations, and other in vivo treatments can be found in the Supplemental Information.
T Cell Purification, Adoptive Transfer, and Recovery Single-cell suspensions were prepared from the spleens and lymph nodes of donor CD45. 
Flow Cytometry
Single-cell suspensions were stained with directly conjugated antibodies to surface markers obtained from eBiosciences, CALTAG/Invitrogen, BD Biosciences, or BioLegend. For intracellular detection of GzmB, spleen cell suspensions were stimulated for 4 hr with phorbol 14,13 dybutirate (PdBu) and ionomycin (both at 500 ng/ml), in the presence of monensin (2 mg/ml). Cells were then stained for surface antigen and washed; after this step, they were fixed and permeabilized using an anti-mouse/rat FoxP3 staining kit (eBioscience), according to the manufacturer's instructions. After an additional wash step, cells were stained for intracellular GzmB with Alexa Fluor 647-or FITC (fluorescein isothiocyanate)-conjugated anti-human/mouse GzmB antibodies (clone GB11, Biolegend) and phycoerythrin (PE)-conjugated anti-mouse IFN-g antibodies (clone XMG1.2, eBioscience). Multi-color cytometry was performed on Canto II or LSRFortessa X-20 flow cytometers (both from BD Biosciences) and analyzed with FlowJo v10 (Tree Star).
Cytotoxicity Assays
Details of in vitro and in vivo cytotoxicity assays can be found in the Supplemental Information.
PCR-Based Expression Profiling
Expression of selected genes was quantified in env-reactive CD4 + T cells by real-time qRT-PCR. The indicated CD4 + T cell populations were purified by cell sorting, and RNA was isolated using the QIAcube (QIAGEN). Synthesis of cDNA was carried out with the High Capacity Reverse Transcription Kit (Applied Biosystems) with an added RNase inhibitor (Promega Biosciences). A final clean-up was performed with the QIAquick PCR Purification Kit (QIAGEN). Purified cDNA was then used as template for the quantitation of the indicated genes using gene-specific primers (Eurofins MWG Operon) (Table S2 ). Values were normalized and plotted according to the expression of Hprt in the same samples, using a DC T method.
Single-Cell RNA Sequencing Env-reactive CD4 + T cells from the indicated recipient mice were purified by cell sorting. A detailed description of subsequent single-cell RNA sequencing can be found in the Supplemental Information.
Statistical Analyses
Statistical comparisons were made using SigmaPlot 12.0 (Systat Software). Parametric comparisons of normally distributed values that satisfied the variance criteria were made by unpaired Student's t tests or one-way ANOVAs.
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Data that did not pass the variance test were compared with non-parametric two-tailed Mann-Whitney rank sum tests or ANOVA on ranks tests. Hierarchical clustering and heatmap production was performed with Qlucore Omics Explorer (Qlucore).
ACCESSION NUMBERS
The accession number for the single-cell RNA sequences reported in this paper is ENA: PRJEB14043. . Naïve Th cell precursors, which do not express Tnfrsf4, are unaffected and they neither gain YFP nor lose Bcl6.
SUPPLEMENTAL INFORMATION
In control Bcl6
wt mice (left), antigen-induced activation of env-specific naïve Th cell precursors leads to Tnfrsf4 transcription in a proportion (70-80%) of cells. In turn, this drives Cre transcription, ultimately leading to YFP expression. In these mice, YFP marks the cells that activate the Tnfrsf4 promoter.
In Bcl6 fl mice (right), additionally carrying the Cre-conditional Bcl6 fl allele, antigen-induced activation of env-specific naïve Th cell precursors leads not only to YFP expression, but also to loss of Bcl6 in the same cells.
The YFP-expressing populations between the two types of donors represent CD4 + T cells at the same state of activation (but differing in Bcl6 expression) and are directly comparable.
Both types of donor CD4
+ T cells also contain YFP-negative effector cells that do not activate the Tnfrsf4 promoter and therefore do not lose the capacity to express Bcl6. These YFP-negative populations additionally serve as internal controls. capture category, a classifier was build using all cells. DESeq2 (Love et al., 2014) was used for initial library size normalization and individual differential expression (DE) analysis of '0'
and 'D' captures against combined '1', 'NS', and 'M' captures. The intersect of the top 250 DE genes for these capture categories was taken, giving a list of 76 genes that were used to build a supervised SVM classifier using the R e1071 package (wrapping LIBSVM) (Chang and Lin, 2011 ) that was auto-tuned to the data. Excluding '0', 'D', and 'M' capture categories, the SVM was applied to '1' and 'NS' cells, providing a numerical likelihood of a sample having better correspondence to a '0' or 'D' capture. Any cells with correspondence 50% or larger were excluded from further analysis. Plots of percentage alignment against number of genes identified for cells passing and failing these filters confirmed that excluded cells frequently had poor alignment rates and lower numbers of genes identified as expressed, although overall read count did not correspond to either of these metrics. Subsequently, samples with <15% alignment rate and those with <1000 genes identified as expressed were additionally excluded. Retained cells from the '1' and 'NS' capture categories were again passed to DESeq2 and DE analysis was performed between various conditions. Normalised count data was exported at this point for further analysis and plotting using Qlucore Omics Explorer (Qlucore, Lund, Sweden). The European Nucleotide Archive (ENA) accession number for the single-cell RNA sequences reported in this paper is PRJEB14043.
Cytotoxicity assays
In vivo cytotoxicity was assessed by the specific killing of peptide-pulsed targets of CD4 
